Replies to post #593887 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I do agree that sometimes she will specifically mention poly-ICLC, but sometimes she will not. However, I believe whether she mentions it or not, it is being used.

However, I do respect and understand your right to disagree with me. But, I will have to go where the evidence takes me.

I am looking at the preponderance of the evidence, not just 1 speech in 2022. I believe that the advantages of using poly-ICLC as an in vivo maturation and activation agent, have been known by Dr. Liau, Dr. Prins, and the other members of the team at UCLA, since 2014, or even before. They will take this knowledge and move forward, not backwards.

Dr. Prins even showed us in 2016, in this graphical depiction below, that poly-ICLC is now automatically included as an in vivo maturation and activation agent when treating patients with DCVax-L:

[newman2021]

I think this Complete super duper combo is the one involved in this $3M prepayment deal. God, wish I do it if I have the resources.